tcf-no-longer-accepting-cases

September 5, 2013 — Medaus Pharmacy has recalled certain lots of injection medications because they cannot confirm that they are sterile. According to the Safety Communication, no injuries have been reported, and the recall is being issued out of an “abundance of caution.”

According to the company’s press release:

“Though Medaus received test results indicating that these lots met all safety standards, they are being recalled because the independent testing lab’s sterility testing practices as applied to these lots indicate that the product’s sterility cannot be confirmed.”

The products were distributed throughout the United States from March 12 until July 22, 2013.

Products involved in the recall include:

Product NameLot #Expiry
Testosterone CYP 200 mg/mL130508-111/16/2013
Lipo injection with lidocaine130510-2611/16/2013
Lipo injection with lidocaine130610-2412/7/2013
Taurine 50 mg/mL PF130618-6412/15/2013
L-Glutathione 200 mg/mL130617-1012/14/2013
Pyridoxine HCl 100 mg/mL NS PF130531-3111/27/2013
Magnesium CHI 200 mg/mL130307-609/3/2013
Sodium ascorbate 500 mg/mL PF130702-112/29/2013
Lipo injection with lidocaine130709-681/5/2014
Sodium ascorbate 500 mg/mL non- corn PF130613-812/10/2013

 

In recent years, contaminated injection medications manufactured by compounding pharmacies have caused deadly outbreaks of infections. The injections can introduce bacteria, fungus, or viruses directly into a person’s body, which increases the risk of a life-threatening infection.

Last year, an outbreak of fungal meningitis was linked to contaminated injections of methylprednisolone acetate, a steroid commonly used to treat back pain. Over 750 people were infected, and 63 died.